AKT1 and cancer: NDUFA4L2 and its binding partners participated in growth and death processes and multiple cancer-related KEGG pathways, such as the IGF-1 (Tracz et al., 2016), mTOR (Populo, Lopes & Soares, 2012) and PI3K/AKT signaling pathways (Guo et al., 2015).